| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/25/2007 | CN1327849C Hemostatic agent and its preparing method |
| 07/25/2007 | CN1327848C Wart treating liquid |
| 07/25/2007 | CN1327847C Externally applied medicine for treating vitiligo and its preparation process |
| 07/25/2007 | CN1327846C Sofflower injection and its prepn. method |
| 07/25/2007 | CN1327845C Chinese medicine for treating cardiovascular and cerebrovascular disease |
| 07/25/2007 | CN1327844C Combination therapy comprising a bisphosphonate and a HMG-COA reductase inhibitor |
| 07/25/2007 | CN1327843C Use of flumazenil to produce medicament for treatment of cocaine dependency |
| 07/25/2007 | CN1327842C Novel compound antineoplastic drug preparing process |
| 07/25/2007 | CN1327841C Novel compound antimalarial preparation method |
| 07/25/2007 | CN1327840C Medicinal composition and its use in treatment of diabetes |
| 07/25/2007 | CN1327839C Matrine capsule and its preparation method |
| 07/25/2007 | CN1327838C Vitamin C oral disintegration tablet and its preparing method |
| 07/25/2007 | CN1327837C Medicine of total coumarins from dried fruits for treating allergic skin disease |
| 07/25/2007 | CN1327836C Composition for treating leukoderma |
| 07/25/2007 | CN1327835C Hepedestal oral disintegration tablet and its preparing method |
| 07/25/2007 | CN1327834C Pharmaceutical composition for prevention and cure of skin pruritus |
| 07/25/2007 | CN1327833C Hawthorn leave flavone capsules and their preparing method |
| 07/25/2007 | CN1327832C Sibuqumin hydrochloride drip pill |
| 07/25/2007 | CN1327831C Method for preparing drug material of swertiamarin |
| 07/25/2007 | CN1327828C New-type slowly releasing solid Naolilong prepn |
| 07/25/2007 | CN1327827C Coated granules based on angiotensin-converting enzyme inhibitor |
| 07/25/2007 | CN1327826C Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
| 07/25/2007 | CN101006181A Process for producing microorganism fat containing diacylglycerol in any amount and the fat |
| 07/25/2007 | CN101006095A 脂肪酶抑制剂 Lipase inhibitors |
| 07/25/2007 | CN101006092A Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 07/25/2007 | CN101006091A Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 07/25/2007 | CN101006090A Hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl)-benzamide, methods for the production thereof |
| 07/25/2007 | CN101006089A Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 07/25/2007 | CN101006088A Fused pyrimidine derivatives and compositions thereof as CXCR3 receptor modulators, useful in prevention and treatment of inflammatory and immunoregulatory disorders and diseases |
| 07/25/2007 | CN101006087A Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors |
| 07/25/2007 | CN101006085A Substituted hydantoins |
| 07/25/2007 | CN101006084A 4-arylmorpholin-3-one derivatives, their preparation and therapeutic use thereof |
| 07/25/2007 | CN101006083A Dpp-iv inhibitors |
| 07/25/2007 | CN101006082A Histamine H3 receptor agents, preparation and therapeutic uses |
| 07/25/2007 | CN101006081A Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol |
| 07/25/2007 | CN101006080A N CC-1065 analogues for use against cancers |
| 07/25/2007 | CN101006079A 嘧啶衍生物 Pyrimidine derivatives |
| 07/25/2007 | CN101006077A Crystalline form of a biphenyl compound |
| 07/25/2007 | CN101006076A Modulators of ATP-binding cassette transporters |
| 07/25/2007 | CN101006075A Bisarylurea derivatives useful for inhibiting CHK1 |
| 07/25/2007 | CN101006074A Piperidine derivatives as NK1 antagonists |
| 07/25/2007 | CN101006072A Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
| 07/25/2007 | CN101006071A Synthesis of polyoxygenated nitrogen systems, comprising reactions between enamines of 1,3-dioxan-5-ones and nitroolefins |
| 07/25/2007 | CN101006066A Arylcycloakyl-substituted alkanoic acid derivatives and its preparation method and uses as drug |
| 07/25/2007 | CN101006065A Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |
| 07/25/2007 | CN101006063A Five-membered heterocycles useful as serine protease inhibitors. |
| 07/25/2007 | CN101006061A 1,5-diphenylpyrazoles |
| 07/25/2007 | CN101006059A Substituted tetrahydroisoquinolines used in the form of MMP inhibitors, method for the production and use thereof in the form of drugs |
| 07/25/2007 | CN101006058A Chemical compounds I |
| 07/25/2007 | CN101006057A Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as moduilators of chemokine receptor CCR5 |
| 07/25/2007 | CN101006056A 3'-alkoxy spirocyclic tetramic and tetronic acids |
| 07/25/2007 | CN101006054A Indoles useful in the treatment of inflammation |
| 07/25/2007 | CN101006053A Indoles useful in the treatment of inflammation |
| 07/25/2007 | CN101006052A Pyrrole derivatives as pharmaceutical agents |
| 07/25/2007 | CN101006047A TRPV1 agonists, formulations containing them and uses thereof |
| 07/25/2007 | CN101005877A Fused triazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 07/25/2007 | CN101005854A Method for augmenting B cell depletion |
| 07/25/2007 | CN101005847A Novel thiazole inhibitors of fructose 1,6-bisphosphatase |
| 07/25/2007 | CN101005846A Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase |
| 07/25/2007 | CN101005845A Muscarinic antagonists with PARP and SIR modulatng activity as agents for inflammatory diseases |
| 07/25/2007 | CN101005844A Muscarinic antagonists with PARP and SIR modulatng activity as agents for inflammatory diseases |
| 07/25/2007 | CN101005843A Pyrrolotriazine kinase inhibitors |
| 07/25/2007 | CN101005842A Modulators of muscarinic receptors |
| 07/25/2007 | CN101005841A 雄激素受体调节剂 Androgen receptor modulators |
| 07/25/2007 | CN101005840A Process to prepare camptothecin derivatives and novel intermediate and compounds thereof |
| 07/25/2007 | CN101005839A Montelukast free acid polymorphs |
| 07/25/2007 | CN101005838A 大麻素受体配体 Cannabinoid receptor ligands |
| 07/25/2007 | CN101005837A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 07/25/2007 | CN101005836A Novel indazole carboxamides and their use |
| 07/25/2007 | CN101005835A 1-[(3r)-amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2r)-carboxylic acid-benzyl amine derivatives and related compounds as dipeptidyl-peptidase iv (dpp-iv) inhibitors for the treatment of type 2 diab |
| 07/25/2007 | CN101005834A Eyewash liquid for dry eye therapy |
| 07/25/2007 | CN101005832A Stable pharmaceutical formulations of benzimidazole compounds |
| 07/25/2007 | CN101005831A Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
| 07/25/2007 | CN101005830A Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 07/25/2007 | CN101005829A Quetiapine formulations |
| 07/25/2007 | CN101005821A Humectant containing alpha-glycosyl glycyrrhizin as active ingredient and use thereof |
| 07/25/2007 | CN101003811A Citron gene of human, coding protein, and application |
| 07/25/2007 | CN101003573A Human antibodies that bind human tnfalpha |
| 07/25/2007 | CN101003558A Glycoside class compound of mango, preparation method, and application in area of medicine |
| 07/25/2007 | CN101003556A Derivative of 10 ¿C hydroxyl camptothecin, prepartion of its liposome, and preparation method |
| 07/25/2007 | CN101003550A Nucleotide compound in halogenating adenine class, synthetic method, medical appliction |
| 07/25/2007 | CN101003548A Rosinyl diterpene modified alpha ¿C phosphoramidate, preparation method, and application for anti tumors |
| 07/25/2007 | CN101003543A Anti infectious compound and usage |
| 07/25/2007 | CN101003542A Sterilization compound in broad spectrum and usage |
| 07/25/2007 | CN101003541A Antibacterial compound in broad spectrum and usage |
| 07/25/2007 | CN101003540A Anti infectious compound and usage |
| 07/25/2007 | CN101003539A Trometamol salt in compound of cillin category, and preparation method |
| 07/25/2007 | CN101003538A [1,4]diazocino[7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents |
| 07/25/2007 | CN101003537A Derivative in pyrrolopyridazine category, preparation method, and application |
| 07/25/2007 | CN101003536A Entecavir salt, and preparation |
| 07/25/2007 | CN101003532A Method for producing antifungal drug in triazole class |
| 07/25/2007 | CN101003526A Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 07/25/2007 | CN101003525A Dicationic compounds which selectively recognize G-quadruplex DNA |
| 07/25/2007 | CN101003521A A compound valeryl biphenyl of valine |
| 07/25/2007 | CN101003520A A compound butyryl biphenyl of valine |
| 07/25/2007 | CN101003515A 4-anilino quinazoline derivatives as antiproliferative agents |
| 07/25/2007 | CN101003514A Derivative of quinazoline, preparation method and usage |
| 07/25/2007 | CN101003513A Compound in quinazoline class or its pharmaceutical salt preparation method, and medical usage |
| 07/25/2007 | CN101003509A New pharmic acceptable salt of pyritinol, and preparation method |
| 07/25/2007 | CN101003500A Sodium sulfonate substitution compound in diphenyl heptane class, and preparation method, and application |